Aptinyx
Evanston, US · Founded 2015 · Delaware corporation · 9 known investors
Find your way into Aptinyx
26 people in our graph share verified history with the Aptinyx team — schools, employers, funds. One of them is your warm intro.
Nicole Vitullounlockedknows Norbert Riedel · together at Agent Capital
×11knows the team · via Agent Capital
Founders & leadership
Aptinyx was founded in 2015 by Joseph R. Moskal.
JR
Joseph R. MoskalChief Scientific Officer
TM
Torsten M. MadsenChief Marketing Officer
AK
Ashish KhannaSecretary & Chief Business Officer
NG
Board
LR
Liam RatcliffeBoard director
TP
Terry P. GouldBoard director
JN
PG
WH
Wilbur H. Gantz IIIBoard director
Investors · 9
Bain Capital Life SciencesBostonvia Adam M. Koppel · board
Frazier Life SciencesPalo Altovia James N. Topper · board
Latterell Venture PartnersSan Ramon · $50K – $10M
Longitude CapitalMenlo Park · $10M – $30M
OUP (Osage University Partners)Bala Cynwyd · $1M – $20M
Agent CapitalreportedWaltham
HBM Healthcare InvestmentsreportedZug
Nan Fung Life SciencesreportedHong Kong
Rock Springs CapitalreportedBaltimore
Reported raises · per SEC filings
Form D private placements$95M disclosed across 2 rounds · 2016–2017
▶$70MraisedDec 2017 · 63 investors · PharmaceuticalsRule 506(b)
▶$70MraisedDec 2017 · 63 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Joseph R. MoskalExecutive Officer
- Terry P. GouldDirector
- Andrew D. KiddExecutive Officer
- James TopperDirector
- Ashish KhannaExecutive Officer
- Torsten M. MadsenExecutive Officer
- Liam RatcliffeDirector
- Adam M. KoppelDirector
- Wilbur H. Gantz IIIDirector
- Norbert G. RiedelExecutive Officer, Director
- Patrick EnrightDirector
- Offering amount
- $70M
- Amount sold
- $70M
- First sale
- Dec 2017
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$25MraisedMay 2016 · 48 investors · PharmaceuticalsRule 506(b)
▶$25MraisedMay 2016 · 48 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Joseph R. MoskalExecutive Officer
- Torsten M. MadsenExecutive Officer
- Liam RatcliffeDirector
- Ashish KhannaExecutive Officer
- Terry P. GouldDirector
- Wilbur H. Gantz IIIDirector
- James N. TopperDirector
- Patrick G. EnrightDirector
- Norbert G. RiedelExecutive Officer, Director
- Offering amount
- $65M
- Amount sold
- $25M
- First sale
- May 2016
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 2 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2016 | $2.3M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2016 | $311.9K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
In the news
Frequently asked questions
- Who founded Aptinyx?
- Aptinyx was founded by Joseph R. Moskal in 2015.
- Who are Aptinyx's investors?
- Aptinyx's investors include Bain Capital Life Sciences, Frazier Life Sciences, Latterell Venture Partners, Longitude Capital, OUP (Osage University Partners), Agent Capital, HBM Healthcare Investments, Nan Fung Life Sciences and 1 more.
- How much funding has Aptinyx raised?
- Aptinyx has disclosed $95M raised across 2 rounds.
- Where is Aptinyx headquartered?
- Aptinyx is headquartered in Evanston, US.